favicon
  • Home
  • Our Research
    • Pipeline to Precision Medicine
    • LKB1 Tumour Suppressor kinase
    • Cytoskeleton
    • Neurodegenerative Diseases
    • Single-Cell Genomic Analysis
    • Funding Resources
  • Team
    • Dr. Paola Marignani
    • Current
    • Alumni
  • Publications
  • Facilities
    • Scientific Links
  • News
  • Contact
✕
  • Home
  • Our Research
    • Pipeline to Precision Medicine
    • LKB1 Tumour Suppressor kinase
    • Cytoskeleton
    • Neurodegenerative Diseases
    • Single-Cell Genomic Analysis
    • Funding Resources
  • Team
    • Dr. Paola Marignani
    • Current
    • Alumni
  • Publications
  • Facilities
    • Scientific Links
  • News
  • Contact
May 2, 2013
May 2, 2013

Dr. Paola Marignani creates a new model for testing potential treatments against aggressive breast cancers

Scientists at Dalhousie Medical School have developed a new and effective way to test potential new treatments for aggressive, metabolically active HER2-positive breast cancers. Dr. Paola […]
Do you like it?
Read more
October 17, 2007
Photo of the Tumour Suppressors team.
October 17, 2007

Marignani organizes team for CIBC Run for the Cure

Do you like it?
Read more
Prev page
12345678
cropped-favicon.png
  • Home
  • Single-Cell Genomic Analysis
  • Pipeline to Precision Medicine
  • Neurodegenerative Diseases
  • LKB1 Tumour Suppressor kinase
  • Cytoskeleton
  • Knowledge Translation
  • Funding Sources
  • Dr. Paola Marignani
  • Current Lab Members
  • Lab Alumni
  • Publications
  • In the News
  • Contact

 

 

Dalhousie University sits on Mi’kma’ki, the ancestral and unceded territory of the Mi’kmaq People. We are all Treaty People. We recognize that African Nova Scotians are a distinct people whose histories, legacies and contributions have enriched that part of Mi’kma’ki known as Nova Scotia for over 400 years.

Pipeline to precision health.
Based in Halifax, Nova Scotia.
© 2025 Marignani Discovery Research Laboratory. All Rights Reserved.